Genetic Polymorphism of DNA Base-excision Repair Genes (APE1, OGG1 and XRCC1) and Their Correlation with Risk of Lung Cancer in a Chinese Population

Archives of Medical Research

Volumn 42, Issue 3, 2011, Pages 226-234

  Li, Zheng ^a   Guan, Wei ^a   Li, Meng xia ^a   Zhong, Zhao yang ^a   Qian, Cheng yuan ^a   Yang, Xue qin ^a   Liao, Ling ^a   Li, Zeng peng ^b   Wang, Dong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Base excision repair; Genetic susceptibility; Genetic variant; Lung cancer; Molecular epidemiology

Indexed keywords

8 HYDROXYGUANINE; 8 OXOGUANINE GLYCOSYLASE 1; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; UNCLASSIFIED DRUG; XRCC1 PROTEIN;

ADULT; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; EXCISION REPAIR; FAMILY HISTORY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ADENOCARCINOMA; AMINO ACID SUBSTITUTION; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA GLYCOSYLASES; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; SMOKING;

EID: 79959715401     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2011.04.005     Document Type: Article

References (48)

1. Hecht S.S. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 2002, 3:461-469.
2. Pampel F.C. Declining sex differences in mortality from lung cancer in high-income nations. Demography 2003, 40:45-65.
3. Pampel F.C. Cigarette diffusion and sex differences in smoking. J Health Soc Behav 2001, 42:388-404.
4. Shibuya K., Inoue M., Lopez A.D. Statistical modeling and projections of lung cancer mortality in 4 industrialized countries. Int J Cancer 2005, 117:476-485.
5. Pharoah P.D., Dunning A., Ponder B.A., et al. Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 2004, 4:850-860.
6. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature 2001, 411:366-374.
7. Wood R.D., Mitchell M., Sgouros J., et al. Human DNA repair genes. Science 2001, 291:1284-1289.
8. Robertson A.B., Klungland A., Rognes T., et al. DNA repair in mammalian cells: base excision repair: the long and short of it. Cell Mol Life Sci 2009, 66:981-993.
9. Belinsky S.A., White C.M., Boucheron J.A., et al. Accumulation and persistence of DNA adducts in respiratory tissue of rats following multiple administrations of the tobacco specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res 1986, 46:1280-1284.
10. Chang J.S., Wrensch M.R., Hansen H.M., et al. Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans. Carcinogenesis 2009, 30:78-87.
11. Kiyohara C., Takayama K., Nakanishi Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer 2006, 54:267-283.
12. Baute J., Depicker A. Base excision repair and its role in maintaining genome stability. Crit Rev Biochem Mol Biol 2008, 43:239-276.
13. Hung R.J., Hall J., Brennan P., et al. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 2005, 162:925-942.
14. Petermann E., Keil C., Oei S.L. Roles of DNA ligase III and XRCC1 in regulating the switch between short patch and long patch BER. DNA Repair (Amst) 2006, 5:544-555.
15. Maynard S., Schurman S.H., Harboe C., et al. Base excision repair of oxidative DNA damage and association with cancer and aging. Carcinogenesis 2009, 30:2-10.
16. Hu Z., Ma H., Chen F., et al. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 2005, 14:1810-1818.
17. Figueroa J.D., Malats N., Real F.X., et al. Genetic variation in the base excision repair pathway and bladder cancer risk. Hum Genet 2007, 121:233-242.
18. Rossner P., Terry M.B., Gammon M.D., et al. OGG1 polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006, 15:811-815.
19. Zhai X.D., Mo Y.N., Xue X.Q., et al. XRCC1 codon 280 and ERCC2 codon 751 polymorphisms and risk of esophageal squamous cell carcinoma in a Chinese population. Bull Cancer 2009, 96:61-65.
20. Cheng X.D., Lu W.G., Ye F., et al. The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma. J Exp Clin Cancer Res 2009, 28:91.
21. Li H., Hao X., Zhang W., et al. The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008, 17:1739-1745.
22. Schneider J., Classen V., Helmig S. XRCC1 polymorphism and lung cancer risk. Expert Rev Mol Diagn 2008, 8:761-780.
23. Agaçhan B., Küçükhüseyin O., Aksoy P., et al. Apurinic/apyrimidinic endonuclease (APE1) gene polymorphisms and lung cancer risk in relation to tobacco smoking. Anticancer Res 2009, 29:2417-2420.
24. Hamajima N. PCR-CTPP: a new genotyping technique in the era of genetic epidemiology. Expert Rev Mol Diagn 2001, 1:119-123.
25. Hatt L., Loft S., Risom L., et al. OGG1 expression and OGG1 Ser326Cys polymorphism and risk of lung cancer in a prospective study. Mutat Res 2008, 639:45-54.
26. Loft S., Svoboda P., Kasai H., et al. Prospective study of 8-oxo-7, 8-dihydro-2'-deoxyguanosine excretion and the risk of lung cancer. Carcinogenesis 2006, 27:1245-1250.
27. Krokan H.E., Nilsen H., Skorpen F., et al. Base excision repair of DNA in mammalian cells. FEBS Lett 2000, 476:73-77.
28. Tudek B. Base excision repair modulation as a risk factor for human cancers. Mol Aspects Med 2007, 28:258-275.
29. Campalans A., Marsin S., Nakabeppu Y., et al. XRCC1 interacts with multiple DNA glycosylases: a model for its recruitment to base excision repair. DNA Repair 2005, 4:826-835.
30. Ladiges W.C. Mouse models of XRCC1 DNA repair polymorphisms and cancer. Oncogene 2006, 25:1612-1619.
31. Fortini P., Pascucci B., Parlanti E., et al. The base excision repair: mechanisms and its relevance for cancer susceptibility. Biochimie 2003, 85:1053-1071.
32. Dalhus B., Laerdahl J.K., Backe P.H., et al. DNA base repair-recognition and initiation of catalysis. FEMS Microbiol Rev 2009, 33:1044-1078.
33. Duell E.J., Holly E.A., Bracci P.M., et al. A population-based study of the Arg399Gln polymorphism in X-ray repair cross-complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res 2002, 62:4630-4636.
34. Qu T., Morimoto K. X-ray repair cross-complementing group 1 polymorphisms and cancer risks in Asian populations: a mini review. Cancer Detect Prev 2005, 29:215-220.
35. Tuimala J., Szekely G., Gundy S., et al. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity. Carcinogenesis 2002, 23:1003-1008.
36. Palli D., Russo A., Masala G., et al. DNA adduct levels and DNA repair polymorphisms in traffic-exposed workers and a general population sample. Int J Cancer 2001, 94:121-127.
37. Pastorelli R., Cerri A., Mezzetti M., et al. Effect of DNA repair gene polymorphisms on BPDEDNA adducts in human lymphocytes. Int J Cancer 2002, 100:9-13.
38. Leng S., Cheng J., Zhang L., et al. The association of XRCC1 haplotypes and chromosomal damage levels in peripheral blood lymphocyte among coke-oven workers. Cancer Epidemiol Biomarkers Prev 2005, 14:1295-1301.
39. Ando K., Hirao S., Kabe Y., et al. A new APE1/Ref-1-dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNA-binding activity. Nucleic Acids Res 2008, 36:4327-4336.
40. Lo Y.L., Jou Y.S., Hsiao C.F., et al. A polymorphism in the APE1 gene promoter is associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev 2009, 18:223-229.
41. Lu J., Zhang S., Chen D., et al. Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility. FASEB J 2009, 23:3459-3469.
42. Santos-Martínez M.J., Curull V., Blanco M.L., et al. Lung cancer at a university hospital: epidemiological and histological characteristics of a recent and a historical series. Arch Bronconeumol 2005, 41:307-312.
43. Hung R.J., Brennan P., Canzian F., et al. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst 2005, 97:567-576.
44. Ito H., Matsuo K., Hamajima N., et al. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk. Carcinogenesi 2004, 25:1395-1401.
45. Mohrenweiser H.W., Wilson D.M., Jones I.M. Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. Mutat Res 2003, 526:93-125.
46. Hu J.J., Smith T.R., Miller M.S., et al. Genetic regulation of ionizing radiation sensitivity and breast cancer risk. Environ Mol Mutagen 2002, 39:208-215.
47. Smith T.R., Levine E.A., Perrier N.D., et al. DNA repair polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2003, 12:1200-1204.
48. Shen M., Hung R.J., Brennan P., et al. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in Northern Italy. Cancer Epidemiol Biomarkers Prev 2003, 12:1234-1240.